Portfolio company
Axol Bioscience
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company supplies human induced pluripotent stem cells and reagents to biopharmaceutical and academic organisations for drug discovery and disease modelling.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Talisman Therapeutics
The company develops human stem cell models of neurodegenerative diseases to provide drug discovery and target validation services for biotechnology and pharmaceutical organisations.
Stemnovate
This company develops human cell-based platforms for drug discovery and toxicity testing to support pharmaceutical firms and research institutions.
bit.bio
The company develops reprogrammed human stem cells for research, drug discovery and cell therapy applications within the pharmaceutical and biotechnology industries.
Oscillution
This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.
PL BioScience
This company manufactures human platelet lysate for use by researchers and pharmaceutical organisations in cell culture and regenerative medicine applications.
Hooke Bio
This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.
Sanguine Biosciences
This company provides human biospecimens and patient data to researchers and pharmaceutical companies to support drug discovery and cell therapy development.
Ncardia (Pluriomics)
Ncardia develops human induced pluripotent stem cell models and assay services for pharmaceutical companies to test drug safety and efficacy.
